Protocol Overview
Dosing Protocol
Standard GI Repair
250 mcg
2x daily (AM + PM, fasted)
Oral
4-8 weeks
Intensive GI Protocol
500 mcg
Maintenance
1x daily (AM, fasted)
Ongoing
Key principle: Take on an empty stomach for direct contact with the gastric and intestinal mucosa. The arginine salt form is preferred for oral use due to superior stability in low pH environments.
Administration Guide
Oral Administration
Form: Capsules (arginine salt preferred)
Timing: 30 min before meals, empty stomach
Morning dose: Upon waking, before breakfast
Evening dose: 2+ hours after last meal
Water: Take with minimal water
Form Comparison
Arginine salt: Best for oral use; acid stable
Acetate salt: Better for injection; less acid stable
Sodium salt: Alternative oral form; moderate stability
Storage: Room temperature, dry, sealed
Shelf life: 12-24 months (capsule form)
Expected Timeline
Side Effects & Monitoring
Common Side Effects
Mild nausea (rare, usually resolves in days)
Slight changes in bowel habits initially
Minimal systemic side effects due to local GI action
Extremely well tolerated in research
BPC-157 has demonstrated an excellent safety profile across numerous preclinical studies with no reported organ toxicity even at high doses.
Precautions
Limited human clinical trial data for oral form
May interact with medications metabolized in the GI tract
Monitor for any changes in existing GI medication needs
Not recommended during pregnancy or breastfeeding
Stacking Recommendations
Compatible Compounds
BPC-157 Injectable: Systemic + local GI coverage
KPV: Anti-inflammatory peptide for IBD support
TB-500: Systemic tissue repair complement
L-Glutamine: Gut lining amino acid support
Zinc Carnosine: Additional gastric mucosal protection
Popular Stacks
GI Repair Stack: BPC-157 Oral 500mcg 2x/day + KPV topical
Full BPC Stack: BPC-157 Oral + BPC-157 SubQ 250mcg/day
Gut Healing: BPC-157 Oral + L-Glutamine 5g/day
Blood Work Recommendations
GI Assessment
Calprotectin, lactulose/mannitol ratio
Baseline, Week 8
Inflammation
CRP, ESR
Baseline, Week 4, Week 8
Liver Function
ALT, AST, GGT
Metabolic
CMP, CBC
Baseline
Fecal calprotectin provides the most direct measure of GI inflammation reduction. Lactulose/mannitol testing assesses intestinal permeability improvements.
Related Tools & Resources
Related Resources